Skip NavigationSkip to Content

Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin

  1. Author:
    Topol, L. Z.
    Bardot, B.
    Zhang, Q. Y.
    Resau, J.
    Huillard, E.
    Marx, M.
    Calothy, G.
    Blair, D. G.
  2. Author Address

    Blair DG NCI, Frederick Canc Res & Dev Ctr, Intramural Res Support Program, SAIC Frederick Frederick, MD 21702 USA NCI, Frederick Canc Res & Dev Ctr, Intramural Res Support Program, SAIC Frederick Frederick, MD 21702 USA NCI, Frederick Canc Res & Dev Ctr, Basic Res Lab Frederick, MD 21702 USA Ctr Univ Orsay, Inst Curie, CNRS, UMR 146 F-91405 Orsay France NCI, Frederick Canc Res & Dev Ctr, Adv BioSci Labs Inc, Basic Res Program Frederick, MD 21702 USA
    1. Year: 2000
  1. Journal: Journal of Biological Chemistry
    1. 275
    2. 12
    3. Pages: 8785-8793
  2. Type of Article: Article
  1. Abstract:

    Down-regulated by mos (Drm)/Gremlin is a highly conserved protein whose properties and expression pattern suggest a role in early development, tissue-specific differentiation, and cell transformation. We have investigated the biosynthesis and processing of Drm expressed endogenously in rat fibroblasts or overexpressed following transient or stable transfection. Analysis of metabolically labeled cells revealed that Drm exists in secreted and cell-associated forms that exhibit similar mobilities in SDS-polyacrylamide gel electrophoresis. Protein analysis indicated that Drm is present in two major species: a slow migrating glycosylated form and a nonglycosylated form. Both forms of Drm are able to undergo phosphorylation. Drm is released into the media within 30 min of synthesis and is detectable for up to 4-5 h, whereas the cell-associated form has a half-life of about 1 h, Confocal immunofluorescent microscopy indicates that Drm is present both on the external surface of expressing cells, as well as within the endoplasmic reticulum and the Golgi. Both glycosylated and nonglycosylated forms of Drm exhibit identical distributions and are able to antagonize bone morphogenetic protein signaling. Like the soluble form, the cell-associated forms are capable of binding I-125-bone morphogenetic protein-4. These properties are consistent with a role for Drm in interfering with signaling and indicate that Drm may act at the cell surface during tissue development and transformation. [References: 36]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel